News & Press Releases – 2023

December 19, 2023 – HSCA Statement for the Record on the Senate Finance Committee’s December 5, 2023, Hearing on Drug Shortages

December 8, 2023 – HSCA Comments to the Senate Committee on Homeland Security and Governmental Affairs (HSGAC)’s Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act

September 20, 2023 – HSCA NAMES CHILDREN’S HOSPITAL ASSOCIATION VICE PRESIDENT OF PHARMACY TERRI LYLE WILSON TO BOARD OF DIRECTORS

August 25, 2023 – HSCA Comments to Energy & Commerce Committee’s Stop Drug Shortages Act Discussion Draft

July 7, 2023 – HSCA Response to Congressional Drug Shortages Request for Information (RFI)

June 28, 2023 – HSCA Comments to EPA on Proposal to Reduce Ethylene Oxide Emissions (EtO) from Commercial Sterilization Facilities and Proposed Interim Decision and Draft Risk Assessment Addendum for Ethylene Oxide

June 5, 2023 – HSCA Response to FDA Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Draft Guidance

May 9, 2023 – HSCA ANNOUNCES INAUGURAL HEALTHCARE SUPPLY CHAIN LEADERSHIP SUMMIT

May 4, 2023 – HEALTHCARE SUPPLY CHAIN ASSOCIATION GROWS MEMBERSHIP, ADDS CAPSTONE HEALTH ALLIANCE AS A MEMBER

April 5, 2023 – HSCA Response to Senate Committee on Health, Education, Labor, and Pensions (HELP) RFI on the Pandemic and All-Hazards Preparedness Act (PAHPA)

March 20, 2023 – HEALTHCARE SUPPLY CHAIN ASSOCIATION ANNOUNCES HSCA CONNECT AFFILIATE PROGRAM TO IMPROVE SUPPLY CHAIN PROCESSES ACROSS THE HEALTHCARE CONTINUUM

March 16, 2023 – HSCA Response to Congressional RFI on the Pandemic and All-Hazards Preparedness Act (PAHPA)

February 8, 2023 – HSCA STATEMENT ON STATE OF THE UNION ADDRESS